Global Genetic Testing Market - Industry Analysis And Market Forecast 2014-2020
LONDON, Oct. 9, 2014 /PRNewswire/ -- Genetic testing is the analysis of genes, chromosomes, or proteins to help predict the risk of disease, identify carriers (individuals who do not have the disease but have a copy of the disease gene) of disease, diagnose disease, or determine the likely course of a disease. Cytogenetics, Molecular Genetics, Cancer Genetics, Prenatal Screening and Prenatal diagnosis are type of genetic tests that involves examining a person's genetic material taken from cells in a sample of blood or, occasionally, from other body fluids or tissues.
Genetic Testing market growth is driven by increasing adoption of oncology applications, growing public awareness and demand for personalized medicine. It advances with aging population and a subsequent rise in the number of chronic diseases, and increasing incidence of cancer cases are the other factors propelling growth in the genetic testing market.
Genetic testing represents the most rapidly expanding segment of the molecular diagnostics market worldwide. Growing incidence of genetic diseases unravels new opportunities for genetic testing. The transformation of genetic testing from being a service-driven market to a product-driven market is expected to provide an impetus to the diagnostic companies for the expansion of their operations.
Genetic Testing market sales are expected to reach $25 billion annually by 2021 with compound annual growth rate of 10% alone in United States. The Global genetic testing market is expected to reach approximately $60 billion by 2020. The US represents the largest market for genetic testing worldwide.
Genetic testing not only identifies the finest cancer treatment for specific patients, but also permits physicians to find if some drugs are unsuitable for a section of patients, while they can be given freely to a majority of others.
This report provides the Genetic Testing Market Forecasting Model, offers valuable insights on global evolution, regional variation, and current market trends. The report also provides Company Profiles with Pipeline Products and financials.
Major players profiled in the report include Abbott Diagnostics, Biocartis SA, bioMerieux S.A., Celera Group, Cepheid, EKF Diagnostics Holdings plc, Genentech, Inc., IntegraGen S.A, Luminex Corporation, Qiagen N.V., Roche Diagnostics Limited, Seegene, Inc., Transgenomic, Inc., among others.
Scope:
Global Market evolution, strategic assessment of Indications market impact analysis, future market and company analysis
Competitive Assessment including Pipeline Product approval analysis
Coverage of Major Players includes company profiles, financials and major products and services.
Download the full report: https://www.reportbuyer.com/product/2377950/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article